Help Privacy Policy Disclaimer
  Advanced SearchBrowse




Journal Article

Metabolic reprogramming of the immune response in the tumor microenvironment


Pearce,  Edward J.
Department Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

External Resource
Fulltext (public)

McCarthy et al..pdf
(Publisher version), 807KB

Supplementary Material (public)
There is no public supplementary material available

McCarthy, S. A., Mufson, R. A., Pearce, E. J., Rathmell, J. C., & Howcroft, T. K. (2013). Metabolic reprogramming of the immune response in the tumor microenvironment. Cancer Biology & Therapy, 14, 315-318. doi:10.4161/cbt.23616.

Cite as: http://hdl.handle.net/21.11116/0000-0006-BEAD-2
A Division of Cancer Biology, NCI sponsored workshop, Metabolic Reprogramming of the Immune Response in the Tumor Microenvironment, was held October 2nd in Bethesda, MD. The purpose of the workshop was to bring together cancer cell biologists and immunologists to explore the mechanistic relationships between the metabolic pathways used by cancer cells and anti-tumor immune cells and how this information could be used to improve cancer immunotherapy. At the conclusion of the workshop a general discussion focused on defining the major challenges and opportunities concerning the impact of metabolism on anti-tumor immunity and cancer immunotherapy as well as what tools, technologies, resources or community efforts are required to accelerate research in this area. Overall, future studies need to consider how cancer cell metabolic pathways differ from activated lymphocytes in order to define a therapeutic window for cancer therapy. Further, studies aimed at reprogramming the metabolic qualities of T cells with the goal of improving immunotherapy were considered a promising avenue.